2018-2023 Global Parkinsons disease Drug Consumption Market Report

October 2018 | 165 pages | ID: 24FEA46F8FDEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Parkinsons disease Drug market for 2018-2023.
Researchers are working to develop new and improved therapies for people with Parkinson's disease (PD). There have been many drugs that have been approved to treat Parkinson disease.

Over the next five years, LPI(LP Information) projects that Parkinsons disease Drug will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Parkinsons disease Drug market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Carbidopa/Levodopa
• Dopamine Receptor Agonists
• MAO-Inhibitors

Segmentation by application:

• Hospital
• Online
• Retail Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Teva
• Novartis AG
• GSK
• AbbVie
• Merck
• Boehringer Ingelheim
• Impax Laboratories
• Lundbeck
• Sun Pharma
• Wockhardt
• UCB
• Valeant Pharmaceuticals
• Acadia

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Parkinsons disease Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Parkinsons disease Drug market by identifying its various subsegments.
• Focuses on the key global Parkinsons disease Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Parkinsons disease Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Parkinsons disease Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL PARKINSONS DISEASE DRUG CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Parkinsons disease Drug Consumption 2013-2023
  2.1.2 Parkinsons disease Drug Consumption CAGR by Region
2.2 Parkinsons disease Drug Segment by Type
  2.2.1 Carbidopa/Levodopa
  2.2.2 Dopamine Receptor Agonists
  2.2.3 MAO-Inhibitors
2.3 Parkinsons disease Drug Consumption by Type
  2.3.1 Global Parkinsons disease Drug Consumption Market Share by Type (2013-2018)
  2.3.2 Global Parkinsons disease Drug Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Parkinsons disease Drug Sale Price by Type (2013-2018)
2.4 Parkinsons disease Drug Segment by Application
  2.4.1 Hospital
  2.4.2 Online
  2.4.3 Retail Pharmacies
2.5 Parkinsons disease Drug Consumption by Application
  2.5.1 Global Parkinsons disease Drug Consumption Market Share by Application (2013-2018)
  2.5.2 Global Parkinsons disease Drug Value and Market Share by Application (2013-2018)
  2.5.3 Global Parkinsons disease Drug Sale Price by Application (2013-2018)

3 GLOBAL PARKINSONS DISEASE DRUG BY PLAYERS

3.1 Global Parkinsons disease Drug Sales Market Share by Players
  3.1.1 Global Parkinsons disease Drug Sales by Players (2016-2018)
  3.1.2 Global Parkinsons disease Drug Sales Market Share by Players (2016-2018)
3.2 Global Parkinsons disease Drug Revenue Market Share by Players
  3.2.1 Global Parkinsons disease Drug Revenue by Players (2016-2018)
  3.2.2 Global Parkinsons disease Drug Revenue Market Share by Players (2016-2018)
3.3 Global Parkinsons disease Drug Sale Price by Players
3.4 Global Parkinsons disease Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Parkinsons disease Drug Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Parkinsons disease Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 PARKINSONS DISEASE DRUG BY REGIONS

4.1 Parkinsons disease Drug by Regions
  4.1.1 Global Parkinsons disease Drug Consumption by Regions
  4.1.2 Global Parkinsons disease Drug Value by Regions
4.2 Americas Parkinsons disease Drug Consumption Growth
4.3 APAC Parkinsons disease Drug Consumption Growth
4.4 Europe Parkinsons disease Drug Consumption Growth
4.5 Middle East & Africa Parkinsons disease Drug Consumption Growth

5 AMERICAS

5.1 Americas Parkinsons disease Drug Consumption by Countries
  5.1.1 Americas Parkinsons disease Drug Consumption by Countries (2013-2018)
  5.1.2 Americas Parkinsons disease Drug Value by Countries (2013-2018)
5.2 Americas Parkinsons disease Drug Consumption by Type
5.3 Americas Parkinsons disease Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Parkinsons disease Drug Consumption by Countries
  6.1.1 APAC Parkinsons disease Drug Consumption by Countries (2013-2018)
  6.1.2 APAC Parkinsons disease Drug Value by Countries (2013-2018)
6.2 APAC Parkinsons disease Drug Consumption by Type
6.3 APAC Parkinsons disease Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Parkinsons disease Drug by Countries
  7.1.1 Europe Parkinsons disease Drug Consumption by Countries (2013-2018)
  7.1.2 Europe Parkinsons disease Drug Value by Countries (2013-2018)
7.2 Europe Parkinsons disease Drug Consumption by Type
7.3 Europe Parkinsons disease Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Parkinsons disease Drug by Countries
  8.1.1 Middle East & Africa Parkinsons disease Drug Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Parkinsons disease Drug Value by Countries (2013-2018)
8.2 Middle East & Africa Parkinsons disease Drug Consumption by Type
8.3 Middle East & Africa Parkinsons disease Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Parkinsons disease Drug Distributors
10.3 Parkinsons disease Drug Customer

11 GLOBAL PARKINSONS DISEASE DRUG MARKET FORECAST

11.1 Global Parkinsons disease Drug Consumption Forecast (2018-2023)
11.2 Global Parkinsons disease Drug Forecast by Regions
  11.2.1 Global Parkinsons disease Drug Forecast by Regions (2018-2023)
  11.2.2 Global Parkinsons disease Drug Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Parkinsons disease Drug Forecast by Type
11.8 Global Parkinsons disease Drug Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Teva
  12.1.1 Company Details
  12.1.2 Parkinsons disease Drug Product Offered
  12.1.3 Teva Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Teva News
12.2 Novartis AG
  12.2.1 Company Details
  12.2.2 Parkinsons disease Drug Product Offered
  12.2.3 Novartis AG Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Novartis AG News
12.3 GSK
  12.3.1 Company Details
  12.3.2 Parkinsons disease Drug Product Offered
  12.3.3 GSK Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 GSK News
12.4 AbbVie
  12.4.1 Company Details
  12.4.2 Parkinsons disease Drug Product Offered
  12.4.3 AbbVie Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 AbbVie News
12.5 Merck
  12.5.1 Company Details
  12.5.2 Parkinsons disease Drug Product Offered
  12.5.3 Merck Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Merck News
12.6 Boehringer Ingelheim
  12.6.1 Company Details
  12.6.2 Parkinsons disease Drug Product Offered
  12.6.3 Boehringer Ingelheim Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Boehringer Ingelheim News
12.7 Impax Laboratories
  12.7.1 Company Details
  12.7.2 Parkinsons disease Drug Product Offered
  12.7.3 Impax Laboratories Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Impax Laboratories News
12.8 Lundbeck
  12.8.1 Company Details
  12.8.2 Parkinsons disease Drug Product Offered
  12.8.3 Lundbeck Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Lundbeck News
12.9 Sun Pharma
  12.9.1 Company Details
  12.9.2 Parkinsons disease Drug Product Offered
  12.9.3 Sun Pharma Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Sun Pharma News
12.10 Wockhardt
  12.10.1 Company Details
  12.10.2 Parkinsons disease Drug Product Offered
  12.10.3 Wockhardt Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Wockhardt News
12.11 UCB
12.12 Valeant Pharmaceuticals
12.13 Acadia

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinsons disease Drug
Table Product Specifications of Parkinsons disease Drug
Figure Parkinsons disease Drug Report Years Considered
Figure Market Research Methodology
Figure Global Parkinsons disease Drug Consumption Growth Rate 2013-2023 (K Doses)
Figure Global Parkinsons disease Drug Value Growth Rate 2013-2023 ($ Millions)
Table Parkinsons disease Drug Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Carbidopa/Levodopa
Table Major Players of Carbidopa/Levodopa
Figure Product Picture of Dopamine Receptor Agonists
Table Major Players of Dopamine Receptor Agonists
Figure Product Picture of MAO-Inhibitors
Table Major Players of MAO-Inhibitors
Table Global Consumption Sales by Type (2013-2018)
Table Global Parkinsons disease Drug Consumption Market Share by Type (2013-2018)
Figure Global Parkinsons disease Drug Consumption Market Share by Type (2013-2018)
Table Global Parkinsons disease Drug Revenue by Type (2013-2018) ($ million)
Table Global Parkinsons disease Drug Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Parkinsons disease Drug Value Market Share by Type (2013-2018)
Table Global Parkinsons disease Drug Sale Price by Type (2013-2018)
Figure Parkinsons disease Drug Consumed in Hospital
Figure Global Parkinsons disease Drug Market: Hospital (2013-2018) (K Doses)
Figure Global Parkinsons disease Drug Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Parkinsons disease Drug Consumed in Online
Figure Global Parkinsons disease Drug Market: Online (2013-2018) (K Doses)
Figure Global Parkinsons disease Drug Market: Online (2013-2018) ($ Millions)
Figure Global Online YoY Growth ($ Millions)
Figure Parkinsons disease Drug Consumed in Retail Pharmacies
Figure Global Parkinsons disease Drug Market: Retail Pharmacies (2013-2018) (K Doses)
Figure Global Parkinsons disease Drug Market: Retail Pharmacies (2013-2018) ($ Millions)
Figure Global Retail Pharmacies YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Parkinsons disease Drug Consumption Market Share by Application (2013-2018)
Figure Global Parkinsons disease Drug Consumption Market Share by Application (2013-2018)
Table Global Parkinsons disease Drug Value by Application (2013-2018)
Table Global Parkinsons disease Drug Value Market Share by Application (2013-2018)
Figure Global Parkinsons disease Drug Value Market Share by Application (2013-2018)
Table Global Parkinsons disease Drug Sale Price by Application (2013-2018)
Table Global Parkinsons disease Drug Sales by Players (2016-2018) (K Doses)
Table Global Parkinsons disease Drug Sales Market Share by Players (2016-2018)
Figure Global Parkinsons disease Drug Sales Market Share by Players in 2016
Figure Global Parkinsons disease Drug Sales Market Share by Players in 2017
Table Global Parkinsons disease Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Parkinsons disease Drug Revenue Market Share by Players (2016-2018)
Figure Global Parkinsons disease Drug Revenue Market Share by Players in 2016
Figure Global Parkinsons disease Drug Revenue Market Share by Players in 2017
Table Global Parkinsons disease Drug Sale Price by Players (2016-2018)
Figure Global Parkinsons disease Drug Sale Price by Players in 2017
Table Global Parkinsons disease Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Parkinsons disease Drug Products Offered
Table Parkinsons disease Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Parkinsons disease Drug Consumption by Regions 2013-2018 (K Doses)
Table Global Parkinsons disease Drug Consumption Market Share by Regions 2013-2018
Figure Global Parkinsons disease Drug Consumption Market Share by Regions 2013-2018
Table Global Parkinsons disease Drug Value by Regions 2013-2018 ($ Millions)
Table Global Parkinsons disease Drug Value Market Share by Regions 2013-2018
Figure Global Parkinsons disease Drug Value Market Share by Regions 2013-2018
Figure Americas Parkinsons disease Drug Consumption 2013-2018 (K Doses)
Figure Americas Parkinsons disease Drug Value 2013-2018 ($ Millions)
Figure APAC Parkinsons disease Drug Consumption 2013-2018 (K Doses)
Figure APAC Parkinsons disease Drug Value 2013-2018 ($ Millions)
Figure Europe Parkinsons disease Drug Consumption 2013-2018 (K Doses)
Figure Europe Parkinsons disease Drug Value 2013-2018 ($ Millions)
Figure Middle East & Africa Parkinsons disease Drug Consumption 2013-2018 (K Doses)
Figure Middle East & Africa Parkinsons disease Drug Value 2013-2018 ($ Millions)
Table Americas Parkinsons disease Drug Consumption by Countries (2013-2018) (K Doses)
Table Americas Parkinsons disease Drug Consumption Market Share by Countries (2013-2018)
Figure Americas Parkinsons disease Drug Consumption Market Share by Countries in 2017
Table Americas Parkinsons disease Drug Value by Countries (2013-2018) ($ Millions)
Table Americas Parkinsons disease Drug Value Market Share by Countries (2013-2018)
Figure Americas Parkinsons disease Drug Value Market Share by Countries in 2017
Table Americas Parkinsons disease Drug Consumption by Type (2013-2018) (K Doses)
Table Americas Parkinsons disease Drug Consumption Market Share by Type (2013-2018)
Figure Americas Parkinsons disease Drug Consumption Market Share by Type in 2017
Table Americas Parkinsons disease Drug Consumption by Application (2013-2018) (K Doses)
Table Americas Parkinsons disease Drug Consumption Market Share by Application (2013-2018)
Figure Americas Parkinsons disease Drug Consumption Market Share by Application in 2017
Figure United States Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure United States Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure Canada Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Canada Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure Mexico Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Mexico Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Table APAC Parkinsons disease Drug Consumption by Countries (2013-2018) (K Doses)
Table APAC Parkinsons disease Drug Consumption Market Share by Countries (2013-2018)
Figure APAC Parkinsons disease Drug Consumption Market Share by Countries in 2017
Table APAC Parkinsons disease Drug Value by Countries (2013-2018) ($ Millions)
Table APAC Parkinsons disease Drug Value Market Share by Countries (2013-2018)
Figure APAC Parkinsons disease Drug Value Market Share by Countries in 2017
Table APAC Parkinsons disease Drug Consumption by Type (2013-2018) (K Doses)
Table APAC Parkinsons disease Drug Consumption Market Share by Type (2013-2018)
Figure APAC Parkinsons disease Drug Consumption Market Share by Type in 2017
Table APAC Parkinsons disease Drug Consumption by Application (2013-2018) (K Doses)
Table APAC Parkinsons disease Drug Consumption Market Share by Application (2013-2018)
Figure APAC Parkinsons disease Drug Consumption Market Share by Application in 2017
Figure China Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure China Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure Japan Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Japan Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure Korea Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Korea Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Southeast Asia Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure India Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure India Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure Australia Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Australia Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Table Europe Parkinsons disease Drug Consumption by Countries (2013-2018) (K Doses)
Table Europe Parkinsons disease Drug Consumption Market Share by Countries (2013-2018)
Figure Europe Parkinsons disease Drug Consumption Market Share by Countries in 2017
Table Europe Parkinsons disease Drug Value by Countries (2013-2018) ($ Millions)
Table Europe Parkinsons disease Drug Value Market Share by Countries (2013-2018)
Figure Europe Parkinsons disease Drug Value Market Share by Countries in 2017
Table Europe Parkinsons disease Drug Consumption by Type (2013-2018) (K Doses)
Table Europe Parkinsons disease Drug Consumption Market Share by Type (2013-2018)
Figure Europe Parkinsons disease Drug Consumption Market Share by Type in 2017
Table Europe Parkinsons disease Drug Consumption by Application (2013-2018) (K Doses)
Table Europe Parkinsons disease Drug Consumption Market Share by Application (2013-2018)
Figure Europe Parkinsons disease Drug Consumption Market Share by Application in 2017
Figure Germany Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Germany Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure France Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure France Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure UK Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure UK Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure Italy Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Italy Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure Russia Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Russia Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure Spain Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Spain Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Parkinsons disease Drug Consumption by Countries (2013-2018) (K Doses)
Table Middle East & Africa Parkinsons disease Drug Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Parkinsons disease Drug Consumption Market Share by Countries in 2017
Table Middle East & Africa Parkinsons disease Drug Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Parkinsons disease Drug Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Parkinsons disease Drug Value Market Share by Countries in 2017
Table Middle East & Africa Parkinsons disease Drug Consumption by Type (2013-2018) (K Doses)
Table Middle East & Africa Parkinsons disease Drug Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Parkinsons disease Drug Consumption Market Share by Type in 2017
Table Middle East & Africa Parkinsons disease Drug Consumption by Application (2013-2018) (K Doses)
Table Middle East & Africa Parkinsons disease Drug Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Parkinsons disease Drug Consumption Market Share by Application in 2017
Figure Egypt Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Egypt Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure South Africa Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure South Africa Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure Israel Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Israel Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure Turkey Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure Turkey Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Parkinsons disease Drug Consumption Growth 2013-2018 (K Doses)
Figure GCC Countries Parkinsons disease Drug Value Growth 2013-2018 ($ Millions)
Table Parkinsons disease Drug Distributors List
Table Parkinsons disease Drug Customer List
Figure Global Parkinsons disease Drug Consumption Growth Rate Forecast (2018-2023) (K Doses)
Figure Global Parkinsons disease Drug Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Parkinsons disease Drug Consumption Forecast by Countries (2018-2023) (K Doses)
Table Global Parkinsons disease Drug Consumption Market Forecast by Regions
Table Global Parkinsons disease Drug Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Parkinsons disease Drug Value Market Share Forecast by Regions
Figure Americas Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Americas Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure APAC Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure APAC Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Europe Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Europe Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Middle East & Africa Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Middle East & Africa Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure United States Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure United States Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Canada Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Canada Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Mexico Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Mexico Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Brazil Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Brazil Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure China Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure China Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Japan Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Japan Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Korea Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Korea Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Southeast Asia Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Southeast Asia Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure India Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure India Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Australia Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Australia Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Germany Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Germany Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure France Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure France Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure UK Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure UK Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Italy Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Italy Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Russia Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Russia Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Spain Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Spain Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Egypt Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Egypt Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure South Africa Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure South Africa Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Israel Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Israel Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure Turkey Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure Turkey Parkinsons disease Drug Value 2018-2023 ($ Millions)
Figure GCC Countries Parkinsons disease Drug Consumption 2018-2023 (K Doses)
Figure GCC Countries Parkinsons disease Drug Value 2018-2023 ($ Millions)
Table Global Parkinsons disease Drug Consumption Forecast by Type (2018-2023) (K Doses)
Table Global Parkinsons disease Drug Consumption Market Share Forecast by Type (2018-2023)
Table Global Parkinsons disease Drug Value Forecast by Type (2018-2023) ($ Millions)
Table Global Parkinsons disease Drug Value Market Share Forecast by Type (2018-2023)
Table Global Parkinsons disease Drug Consumption Forecast by Application (2018-2023) (K Doses)
Table Global Parkinsons disease Drug Consumption Market Share Forecast by Application (2018-2023)
Table Global Parkinsons disease Drug Value Forecast by Application (2018-2023) ($ Millions)
Table Global Parkinsons disease Drug Value Market Share Forecast by Application (2018-2023)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Parkinsons disease Drug Market Share (2016-2018)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis AG Parkinsons disease Drug Market Share (2016-2018)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GSK Parkinsons disease Drug Market Share (2016-2018)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AbbVie Parkinsons disease Drug Market Share (2016-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Parkinsons disease Drug Market Share (2016-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Boehringer Ingelheim Parkinsons disease Drug Market Share (2016-2018)
Table Impax Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Impax Laboratories Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Impax Laboratories Parkinsons disease Drug Market Share (2016-2018)
Table Lundbeck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lundbeck Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lundbeck Parkinsons disease Drug Market Share (2016-2018)
Table Sun Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharma Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sun Pharma Parkinsons disease Drug Market Share (2016-2018)
Table Wockhardt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Wockhardt Parkinsons disease Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Wockhardt Parkinsons disease Drug Market Share (2016-2018)
Table UCB Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acadia Basic Information, Manufacturing Base, Sales Area and Its Competitors